CTCFL Regulates the PI3K-Akt Pathway and It Is a Target for Personalized Ovarian Cancer Therapy

The authors used in vitro models to evaluate the transcriptional changes due to the presence of CTCFL, followed by a selection of gene candidates using de novo network enrichment analysis.